Cabaylo, Victoria M.

HRN: 25-54-73  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/07/2024
CEFTRIAXONE 1G (VIAL)
10/07/2024
10/14/2024
IV
2gms
Od
Uti
Waiting Final Action 
10/10/2024
MUPIROCIN 2%, 15G (TUBE)
10/10/2024
10/17/2024
TOPICAL
15g
Bid
Non Healing Wound
Waiting Final Action 
10/12/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/12/2024
10/19/2024
IV
600mg
Q8H
Non Healing Wound, 3rd Digit Right Foot
Waiting Final Action 
10/16/2024
MUPIROCIN 2%, 15G (TUBE)
10/16/2024
10/22/2024
TOPICAL
Apply On Affected Areas
Bid
Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: